SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Vaccines

PUBLISHER: Polaris Market Research | PRODUCT CODE: 2109775

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 2109775

Vaccine Adjuvants Market Size, Share, & Industry Analysis Report: By Product Type, Route of Administration, Disease Type, Application, and Region - Market Forecast, 2026-2034

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

Description

Table of Contents

List of Tables

The global vaccine adjuvants market size is expected to reach USD 6.04 billion by 2034, according to a new study by Polaris Market Research. The report "Vaccine Adjuvants Market Size, Share, Trends, Industry Analysis Report: By Product Type (Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Alum, and Others), Route of Administration, Disease Type, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2026-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The vaccine adjuvants market involves substances added to vaccines to enhance immune responses. These adjuvants improve the efficacy of vaccines, particularly for challenging diseases. Growing demand for vaccines, advancements in adjuvant technologies, and increased awareness of immunization are driving market growth. Key players focus on developing new adjuvants with improved safety and effectiveness. The market is fueled by rising vaccination programs and the need for vaccines against emerging diseases, including COVID-19.

The vaccine adjuvants market growth is driven by the increasing demand for effective vaccines, particularly for infectious diseases and cancer immunotherapy. Key drivers include the rising incidence of infectious diseases across the world, the increasing need for enhanced vaccine efficacy, and continued government and private sector investments in vaccine development. Vaccine adjuvant market opportunities lie in the development of next-generation adjuvants with better safety profiles and the growing use of adjuvants in personalized medicine, including cancer vaccines. Market trends include a shift toward more advanced adjuvant technologies, such as liposome-based and saponin-based adjuvants, and the expansion of vaccine research in response to emerging health threats. Overall, the market is poised for steady growth, supported by innovation, strategic collaborations, and increasing healthcare needs worldwide.

Vaccine Adjuvants Market Report Highlights

Based on product type, the alum segment holds the largest market share due to its long-standing use in vaccines and proven safety. However, adjuvant emulsions are the fastest-growing segment, driven by their enhanced immune response in vaccines for infectious diseases and pandemics.

By route of administration, the intramuscular route segment dominates the market due to its widespread use in vaccines for various infectious diseases, such as influenza and COVID-19. The subcutaneous route is registering the highest growth, particularly in therapeutic vaccines and immunotherapy applications.

In terms of disease type, the infectious diseases segment dominates the vaccine adjuvants market revenue share, driven by ongoing vaccination programs for diseases such as influenza, hepatitis, and COVID-19. The cancer segment is experiencing the highest growth, fueled by advancements in immunotherapy vaccines and personalized medicine.

The commercial application segment, by application, leads the vaccine adjuvants market share owing to the widespread use of adjuvanted vaccines in public health initiatives globally. The research application segment is growing the fastest, supported by increased investments in vaccine development and clinical trials, especially in cancer and therapeutic vaccines.

North America holds the largest market share due to its strong healthcare infrastructure and substantial vaccine research investments. Asia Pacific is registering the highest growth, driven by expanding healthcare needs, large populations, and increasing vaccine adoption.

Polaris Market Research has segmented the vaccine adjuvants market report on the basis of product type, route of administration, disease type, application, and region:

By Product Type Outlook (Revenue-USD Billion, 2021-2034)

Particulate Adjuvants

Adjuvant Emulsions

Pathogen Components

Alum

Others

By Route of Administration Outlook (Revenue - USD Billion, 2021-2034)

Intramuscular Route

Subcutaneous Route

Others

By Disease Type Outlook (Revenue - USD Billion, 2021-2034)

Infectious Diseases

Cancer

Others

By Application Outlook (Revenue - USD Billion, 2021-2034)

Research Application

Commercial Application

By Regional Outlook (Revenue - USD Billion, 2021-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Show more
Product Code: PM1684

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Vaccine Adjuvants Market Insights

  • 4.1. Vaccine Adjuvants Market - Market Snapshot
  • 4.2. Vaccine Adjuvants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Focus on Advanced Adjuvant Technologies
      • 4.2.1.2. Growing Role of Adjuvants in Pandemic Preparedness
      • 4.2.1.3. Expansion of Personalized Vaccine Adjuvant Strategies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory Challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Vaccine Adjuvants Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Vaccine Adjuvants Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • 5.3. Particulate Adjuvants
    • 5.3.1. Global Vaccine Adjuvants Market, by Particulate Adjuvants, by Region, 2021-2034 (USD Billion)
  • 5.4. Adjuvant Emulsions
    • 5.4.1. Global Vaccine Adjuvants Market, by Adjuvant Emulsions, by Region, 2021-2034 (USD Billion)
  • 5.5. Pathogen Components
    • 5.5.1. Global Vaccine Adjuvants Market, by Pathogen Components, by Region, 2021-2034 (USD Billion)
  • 5.6. Alum
    • 5.6.1. Global Vaccine Adjuvants Market, by Alum, by Region, 2021-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Vaccine Adjuvants Market, by Others, by Region, 2021-2034 (USD Billion)

6. Global Vaccine Adjuvants Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • 6.3. Intramuscular Route
    • 6.3.1. Global Vaccine Adjuvants Market, by Intramuscular Route, by Region, 2021-2034 (USD Billion)
  • 6.4. Subcutaneous Route
    • 6.4.1. Global Vaccine Adjuvants Market, by Subcutaneous Route, by Region, 2021-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Vaccine Adjuvants Market, by Others, by Region, 2021-2034 (USD Billion)

7. Global Vaccine Adjuvants Market, by Disease Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • 7.3. Infectious Diseases
    • 7.3.1. Global Vaccine Adjuvants Market, by Infectious Diseases, by Region, 2021-2034 (USD Billion)
  • 7.4. Cancer
    • 7.4.1. Global Vaccine Adjuvants Market, by Cancer, by Region, 2021-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Vaccine Adjuvants Market, by Others, by Region, 2021-2034 (USD Billion)

8. Global Vaccine Adjuvants Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • 8.3. Research Application
    • 8.3.1. Global Vaccine Adjuvants Market, by Research Application, by Region, 2021-2034 (USD Billion)
  • 8.4. Commercial Application
    • 8.4.1. Global Vaccine Adjuvants Market, by Commercial Application, by Region, 2021-2034 (USD Billion)

9. Global Vaccine Adjuvants Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Vaccine Adjuvants Market Assessment, By Geography, 2021-2034 (USD Billion)
  • 9.3. Vaccine Adjuvants Market - North America
    • 9.3.1. North America: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
    • 9.3.2. North America: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
    • 9.3.3. North America: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
    • 9.3.4. North America: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.3.5. Vaccine Adjuvants Market - US
      • 9.3.5.1. US: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.3.5.2. US: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.3.5.3. US: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.3.5.4. US: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.3.6. Vaccine Adjuvants Market - Canada
      • 9.3.6.1. Canada: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.3.6.2. Canada: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.3.6.3. Canada: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.3.6.4. Canada: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • 9.4. Vaccine Adjuvants Market - Europe
    • 9.4.1. Europe: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
    • 9.4.2. Europe: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
    • 9.4.3. Europe: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
    • 9.4.4. Europe: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.4.5. Vaccine Adjuvants Market - UK
      • 9.4.5.1. UK: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.5.2. UK: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.4.5.3. UK: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.4.5.4. UK: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.4.6. Vaccine Adjuvants Market - France
      • 9.4.6.1. France: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.6.2. France: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.4.6.3. France: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.4.6.4. France: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.4.7. Vaccine Adjuvants Market - Germany
      • 9.4.7.1. Germany: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.7.2. Germany: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.4.7.3. Germany: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.4.7.4. Germany: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.4.8. Vaccine Adjuvants Market - Italy
      • 9.4.8.1. Italy: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.8.2. Italy: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.4.8.3. Italy: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.4.8.4. Italy: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.4.9. Vaccine Adjuvants Market - Spain
      • 9.4.9.1. Spain: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.9.2. Spain: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.4.9.3. Spain: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.4.9.4. Spain: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.4.10. Vaccine Adjuvants Market - Netherlands
      • 9.4.10.1. Netherlands: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.4.11. Vaccine Adjuvants Market - Russia
      • 9.4.11.1. Russia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.11.2. Russia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.4.11.3. Russia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.4.11.4. Russia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.4.12. Vaccine Adjuvants Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • 9.5. Vaccine Adjuvants Market - Asia Pacific
    • 9.5.1. Asia Pacific: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.5.5. Vaccine Adjuvants Market - China
      • 9.5.5.1. China: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.5.2. China: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.5.5.3. China: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.5.5.4. China: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.5.6. Vaccine Adjuvants Market - India
      • 9.5.6.1. India: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.6.2. India: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.5.6.3. India: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.5.6.4. India: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.5.7. Vaccine Adjuvants Market - Malaysia
      • 9.5.7.1. Malaysia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.5.8. Vaccine Adjuvants Market - Japan
      • 9.5.8.1. Japan: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.8.2. Japan: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.5.8.3. Japan: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.5.8.4. Japan: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.5.9. Vaccine Adjuvants Market - Indonesia
      • 9.5.9.1. Indonesia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.5.10. Vaccine Adjuvants Market - South Korea
      • 9.5.10.1. South Korea: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.10.2. South Korea: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.5.10.3. South Korea: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.5.10.4. South Korea: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.5.11. Vaccine Adjuvants Market - Australia
      • 9.5.11.1. Australia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.11.2. Australia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.5.11.3. Australia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.5.11.4. Australia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.5.12. Vaccine Adjuvants Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • 9.6. Vaccine Adjuvants Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.6.5. Vaccine Adjuvants Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.6.6. Vaccine Adjuvants Market - UAE
      • 9.6.6.1. UAE: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.6.2. UAE: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.6.6.3. UAE: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.6.6.4. UAE: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.6.7. Vaccine Adjuvants Market - Israel
      • 9.6.7.1. Israel: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.7.2. Israel: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.6.7.3. Israel: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.6.7.4. Israel: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.6.8. Vaccine Adjuvants Market - South Africa
      • 9.6.8.1. South Africa: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.8.2. South Africa: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.6.8.3. South Africa: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.6.8.4. South Africa: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.6.9. Vaccine Adjuvants Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • 9.7. Vaccine Adjuvants Market - Latin America
    • 9.7.1. Latin America: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
    • 9.7.2. Latin America: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
    • 9.7.3. Latin America: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
    • 9.7.4. Latin America: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.7.5. Vaccine Adjuvants Market - Mexico
      • 9.7.5.1. Mexico: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.7.5.2. Mexico: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.7.5.3. Mexico: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.7.5.4. Mexico: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.7.6. Vaccine Adjuvants Market - Brazil
      • 9.7.6.1. Brazil: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.7.6.2. Brazil: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.7.6.3. Brazil: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.7.6.4. Brazil: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.7.7. Vaccine Adjuvants Market - Argentina
      • 9.7.7.1. Argentina: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.7.7.2. Argentina: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.7.7.3. Argentina: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.7.7.4. Argentina: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
    • 9.7.8. Vaccine Adjuvants Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. GlaxoSmithKline (GSK)
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Novavax
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Merck & Co.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Sanofi
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. CSL Limited
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Adjuvance Technologies
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. SEPPIC
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Croda International
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Vaxine Pty Ltd
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Brenntag Biosector
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Vaccitech (University of Oxford spin-off)
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Emergent BioSolutions
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Avanti Polar Lipids
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Daiichi Sankyo
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. ImmunoScience
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
Show more
Product Code: PM1684

List of Tables:

  • Table 1 Global Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 2 Global Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 3 Global Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 4 Global Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 5 North America: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 6 North America: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 7 North America: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 8 North America: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 9 U.S.: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 10 U.S.: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 11 U.S.: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 12 U.S.: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 13 Canada: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 14 Canada: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 15 Canada: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 16 Canada: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 17 Europe: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 18 Europe: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 19 Europe: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 20 Europe: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 21 UK: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 22 UK: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 23 UK: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 24 UK: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 25 France: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 26 France: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 27 France: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 28 France: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 29 Germany: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 30 Germany: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 31 Germany: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 32 Germany: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 33 Italy: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 34 Italy: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 35 Italy: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 36 Italy: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 37 Spain: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 38 Spain: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 39 Spain: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 40 Spain: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 41 Netherlands: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 42 Netherlands: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 43 Netherlands: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 44 Netherlands: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 45 Russia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 46 Russia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 47 Russia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 48 Russia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 49 Rest of Europe: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 50 Rest of Europe: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 51 Rest of Europe: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 52 Rest of Europe: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 53 Asia Pacific: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 54 Asia Pacific: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 55 Asia Pacific: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 56 Asia Pacific: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 57 China: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 58 China: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 59 China: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 60 China: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 61 India: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 62 India: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 63 India: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 64 India: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 65 Malaysia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 66 Malaysia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 67 Malaysia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 68 Malaysia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 69 Japan: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 70 Japan: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 71 Japan: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 72 Japan: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 73 Indonesia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 74 Indonesia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 75 Indonesia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 76 Indonesia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 77 South Korea: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 78 South Korea: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 79 South Korea: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 80 South Korea: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 81 Australia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 82 Australia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 83 Australia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 84 Australia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 89 Middle East & Africa: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 90 Middle East & Africa: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 91 Middle East & Africa: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 92 Middle East & Africa: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 93 Saudi Arabia: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 94 Saudi Arabia: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 95 Saudi Arabia: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 96 Saudi Arabia: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 97 UAE: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 98 UAE: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 99 UAE: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 100 UAE: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 101 Israel: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 102 Israel: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 103 Israel: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 104 Israel: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 105 South Africa: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 106 South Africa: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 107 South Africa: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 108 South Africa: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 113 Latin America: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 114 Latin America: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 115 Latin America: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 116 Latin America: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 117 Mexico: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 118 Mexico: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 119 Mexico: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 120 Mexico: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 121 Brazil: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 122 Brazil: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 123 Brazil: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 124 Brazil: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 125 Argentina: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 126 Argentina: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 127 Argentina: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 128 Argentina: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)
  • Table 129 Rest of Latin America: Vaccine Adjuvants Market, by Product Type, 2021-2034 (USD Billion)
  • Table 130 Rest of Latin America: Vaccine Adjuvants Market, by Route of Administration, 2021-2034 (USD Billion)
  • Table 131 Rest of Latin America: Vaccine Adjuvants Market, by Application, 2021-2034 (USD Billion)
  • Table 132 Rest of Latin America: Vaccine Adjuvants Market, by Disease Type, 2021-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Vaccine Adjuvants Market, 2021-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Vaccine Adjuvants Market, by Product Type, 2025 & 2034 (USD Billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Vaccine Adjuvants Market, by Route of Administration, 2025 & 2034 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Vaccine Adjuvants Market, by Application, 2025 & 2034 (USD Billion)
  • Figure 12. Market by Disease Type
  • Figure 13. Global Vaccine Adjuvants Market, by Disease Type, 2025 & 2034 (USD Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!